-
But King agrees that the approval for Truvada is a good thing, and that the drug's marketing label is also positive.
FORBES: Biotechs Sweat Out A Bad Season
-
Truvada isn't approved by the Food and Drug Administration for use to prevent HIV, but physicians can prescribe any approved drugs as they see fit.
WSJ: Daily Pill Slashes Risk of HIV Infection in Study
-
So much concern swirls around the pipeline or lack of promising blockbusters there to replace Atripla and Truvada, but there is still time to discover them yet.
FORBES: Order A Double Of HIV Cocktail King Gilead Sciences
-
Mr Tonges said he was taking Truvada, a drug just approved in the US for HIV prevention, while officials investigated for "any type of substance on the needle".
BBC: Needles found in Delta Air Lines on-board sandwiches
-
One is an HIV drug that combines Gilead's Truvada (which itself is a combo of two Gilead drugs to treat HIV) and Sustiva from Bristol-Myers Squibb into a one-pill, once-a-day regimen.
FORBES
-
One is an HIV drug that combines Gilead's Truvada (which itself is a combo of two Gilead drugs to treat HIV) and Sustiva from Bristol-Myers Squibb (nyse: BMY - news - people ) into a one-pill, once-a-day regimen.
FORBES: Gilead's Half-Empty Pipeline
-
But at the same time, the drugmaker boosted prices for its meds in the commercial market: a 7.9 percent increase on Truvada, a 7.3 percent increase for Complera and a 6.6 percent increase on Atripla, which raises costs for privately insured and Medicare patients.
FORBES: Gilead Warned By Democrats Over 'Quad' Pricing